Glaukos Operating Income 2014-2023 | GKOS
- Glaukos operating income for the quarter ending December 31, 2023 was $-0.039B, a 14.49% increase year-over-year.
- Glaukos operating income for the twelve months ending December 31, 2023 was $-0.129B, a 56.35% increase year-over-year.
- Glaukos annual operating income for 2023 was $-0.129B, a 56.35% increase from 2022.
- Glaukos annual operating income for 2022 was $-0.082B, a 150.4% increase from 2021.
- Glaukos annual operating income for 2021 was $-0.033B, a 73.39% decline from 2020.
Glaukos Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $-129 |
2022 | $-82 |
2021 | $-33 |
2020 | $-124 |
2019 | $-50 |
2018 | $-13 |
2017 | $-2 |
2016 | $4 |
2015 | $-10 |
2014 | $-13 |
2013 | $-14 |
Glaukos Quarterly Operating Income (Millions of US $) |
|
---|---|
2023-12-31 | $-39 |
2023-09-30 | $-28 |
2023-06-30 | $-29 |
2023-03-31 | $-33 |
2022-12-31 | $-34 |
2022-09-30 | $-22 |
2022-06-30 | $-37 |
2022-03-31 | $10 |
2021-12-31 | $-18 |
2021-09-30 | $11 |
2021-06-30 | $-14 |
2021-03-31 | $-12 |
2020-12-31 | $-11 |
2020-09-30 | $-12 |
2020-06-30 | $-47 |
2020-03-31 | $-53 |
2019-12-31 | $-30 |
2019-09-30 | $-12 |
2019-06-30 | $-6 |
2019-03-31 | $-2 |
2018-12-31 | $2 |
2018-09-30 | $-7 |
2018-06-30 | $-4 |
2018-03-31 | $-4 |
2017-12-31 | $1 |
2017-09-30 | $1 |
2017-06-30 | $-4 |
2017-03-31 | $0 |
2016-12-31 | $0 |
2016-09-30 | $1 |
2016-06-30 | $2 |
2016-03-31 | $1 |
2015-12-31 | $-2 |
2015-09-30 | $-2 |
2015-06-30 | $-5 |
2015-03-31 | $-1 |
2014-12-31 | $-5 |
2014-09-30 | $-2 |
2014-06-30 | $-2 |
2014-03-31 | $-4 |
2013-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $5.610B | $0.315B |
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $228.656B | 27.71 |
Intuitive Surgical (ISRG) | United States | $141.664B | 85.34 |
Edwards Lifesciences (EW) | United States | $54.330B | 35.36 |
DexCom (DXCM) | United States | $51.584B | 78.14 |
IDEXX Laboratories (IDXX) | United States | $45.302B | 53.10 |
Alcon (ALC) | Switzerland | $44.364B | 31.79 |
IQVIA Holdings (IQV) | United States | $42.578B | 24.70 |
STERIS (STE) | Ireland | $23.267B | 27.19 |
Waters (WAT) | United States | $21.461B | 31.54 |
SONOVA HOLDING (SONVY) | Switzerland | $19.656B | 0.00 |
Hologic (HOLX) | United States | $17.471B | 19.55 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $13.151B | 15.35 |
ShockWave Medical (SWAV) | United States | $12.422B | 77.31 |
Sysmex ADR (SSMXY) | Japan | $11.022B | 34.56 |
Teleflex (TFX) | United States | $10.353B | 16.11 |
Globus Medical (GMED) | United States | $8.736B | 25.61 |
Penumbra (PEN) | United States | $7.935B | 90.18 |
Masimo (MASI) | United States | $6.166B | 35.52 |
TransMedics (TMDX) | United States | $4.484B | 425.44 |
Integer Holdings (ITGR) | United States | $3.944B | 23.83 |
PROCEPT BioRobotics (PRCT) | United States | $3.558B | 0.00 |
LivaNova (LIVN) | United Kingdom | $3.422B | 20.32 |
Tandem Diabetes Care (TNDM) | United States | $3.060B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.923B | 20.05 |
Inari Medical (NARI) | United States | $2.732B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.428B | 20.53 |
RxSight (RXST) | United States | $2.378B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $2.086B | 9.10 |
Veracyte (VCYT) | United States | $1.800B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.604B | 0.00 |
Artivion (AORT) | United States | $0.990B | 94.92 |
OPKO Health (OPK) | United States | $0.941B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.919B | 17.88 |
Silk Road Medical (SILK) | United States | $0.854B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.748B | 0.00 |
Paragon 28 (FNA) | United States | $0.672B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.640B | 21.72 |
SiBone (SIBN) | United States | $0.623B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.584B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
IRadimed (IRMD) | United States | $0.534B | 29.89 |
Pulse Biosciences (PLSE) | United States | $0.401B | 0.00 |
Nevro (NVRO) | United States | $0.388B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.325B | 11.13 |
Sight Sciences (SGHT) | United States | $0.276B | 0.00 |
AxoGen (AXGN) | United States | $0.260B | 0.00 |
NeuroPace (NPCE) | United States | $0.260B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.255B | 0.00 |
AngioDynamics (ANGO) | United States | $0.255B | 0.00 |
908 Devices (MASS) | United States | $0.250B | 0.00 |
Inogen (INGN) | United States | $0.208B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.202B | 0.00 |
Delcath Systems (DCTH) | United States | $0.200B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.175B | 0.00 |
CVRx (CVRX) | United States | $0.174B | 0.00 |
Accuray (ARAY) | United States | $0.168B | 0.00 |
Semler Scientific (SMLR) | United States | $0.167B | 8.49 |
Yubo Biotech (YBGJ) | China | $0.109B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.107B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.101B | 21.17 |
Neuronetics (STIM) | United States | $0.073B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
Hyperfine (HYPR) | United States | $0.063B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.060B | 0.00 |
Envoy Medical (COCH) | United States | $0.059B | 0.00 |
InspireMD (NSPR) | Israel | $0.057B | 0.00 |
DarioHealth (DRIO) | United States | $0.055B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.051B | 0.00 |
LENSAR (LNSR) | United States | $0.047B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
Precision Optics (POCI) | United States | $0.040B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.034B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.033B | 0.00 |
Spectral AI (MDAI) | United States | $0.029B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
PAVmed (PAVM) | United States | $0.018B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
NexGel (NXGL) | United States | $0.014B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
Tenon Medical (TNON) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |